Martin Shkreli is back.
The infamous “pharma bro,” who was released from prison two months ago, announced the creation of Druglike, a “web3 drug discovery software platform” that seeks to “disrupt the economics of the drug business,” according to a press release.
Whether it will actually go anywhere or is just another one of Shkreli’s stunts, is yet to be seen. But given how much of web3.0 appears to be money-making schemes that defraud investors, it is an auspicious industry for Shkreli to enter into.
Shkreli became notorious after he hiked the price of the life-saving drug Daraprim by more than 5,000% overnight in 2015, earning the condemnation of both then-Republican presidential candidate Donald Trump and Democratic candidate Hillary Clinton.
Shkreli, who was just released from a seven-year prison sentence for securities fraud for his misdeeds around the healthcare market, is listed as the company’s co-founder. It is unclear whether this violates his lifetime ban from the drug industry he received earlier this year.
According to the release, Druglike will use the blockchain to aid in drug discovery and development, creating a “decentralized computing network” to provide resources for people “looking to start or contribute to early-stage drug discovery projects.”
“For the first time, any computer or phone with access to the web might be responsible and rewarded for discovering the next breakthrough medicine,”…
